Clinical Trial Update: Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study of neoadjuvant Cemiplimab plus Imiquimod and laser therapy for cutaneous basal cell carcinoma, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Aldara (imiquimod)
• Libtayo (cemiplimab)

Snippet

Sponsor: Instituto Oncológico Dr Rosell | Conditions: Cutaneous Basal Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING